Characteristics of peri-operative medications for elder patients with coronary heart disease undergoing percutaneous coronary intervention:clinical analysis of 13 049 cases

Yu-Nuo WANG,Heng WU,Yi LI,Xiao-Zeng WANG,Jing LI,Quan-Min JING,Ying-Yan MA,Ya-Ling HAN
DOI: https://doi.org/10.3724/SP.J.1264.2014.00097
2014-01-01
Chinese Journal of Multiple Organ Diseases in the Elderly
Abstract:Objective To determine the characteristics of peri-operative medications in the elderly patients with coronary heart diseases (CHD) undergoing percutaneous coronary intervention (PCI). Methods Clinical data of 13 049 patients with CHD undergoing PCI in Shenyang General Hospital of Shenyang Military Command from July 2008 to November 2012 were collected and retrospectively analyzed. The cohort of patients were divided into non-aged (<60 years old, n=5810), younger aged (≤60 to <74 years old, n=5640) and senior aged (≥75 years old, n=1 599) groups according to their age. Their characteristics of peri-operative medications were analyzed and compared among the 3 groups. Results With the increase in age, the proportions of comorbidities such as hypertension, cardiac arrhythmia, renal insufficiency and prior stroke were significantly elevated. There were less patients receiving thrombolytic therapy with the increase in their age (17.5% vs 14.3% vs 7.2%, P<0.001). The percentage of using platelet glucose protein Ⅱb/Ⅲa receptor inhibitors was significantly decreased with the increased age (32.4% vs 27.2% vs 11.0%, P<0.001). There was no significant difference between the younger aged and non-aged patients in using of loading dose of aspirin, clopidogrel and high maintenance dose of aspirin (99.3%vs 98.4%, 93.7% vs 93.8%, 55.4% vs 55.9%, all P>0.05), but percentages of the 2 groups were significantly higher than the senior aged group (88.7%, P<0.001; 91.5%, P=0.006; 47.6%, P<0.001). No obvious difference was seen in the peri-operative dose of heparin therapy among the 3 groups. More patients from younger and senior aged groups received fondaparinux sodium therapy than the non-aged one (35.9%vs 38.0%vs 38.7%, P=0.026). The uses of foundational cardiovascular medications (including angiotensin Ⅱ receptor antagonists,calcium channel blockes, diuretics, digitalis and sodium nitroprusside) were more common in the aged patients than in non-aged group. Conclusion There are less patients receiving thrombolytic and antithrombotic therapies in the aged than the non-aged patients undergoing PCI, but the former patients have high proportion of foundational cardiovascular therapies.
What problem does this paper attempt to address?